Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer

Intravesical instillation of chemotherapeutic agents is a well-established treatment strategy to decrease recurrence following transurethral resection in non-muscle invasive bladder cancer. Gemcitabine is a recently developed treatment option. However, the curative effects of gemcitabine are far fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Ho Kyung, Ahn, Kyung-Ohk, Jung, Nae-Rae, Shin, Ji-Sun, Park, Weon Seo, Lee, Kang Hyun, Lee, Sang-Jin, Jeong, Kyung-Chae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964210/
https://www.ncbi.nlm.nih.gov/pubmed/24504118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964210/
https://www.ncbi.nlm.nih.gov/pubmed/24504118

Ejemplares similares